References
K. V. Voronkov, A. S. Petrukhin, O. A. Pylaeva, and A. A. Kholin, Rational Antiepileptic Pharmacotherapy. Guidelines for Doctors [in Russian], Binom, Moscow (2008).
A. B. Gekht, G. N. Avakyan, and E. I. Gusev, “Current standards in the diagnosis and treatment of epilepsy in Europe,” Zh. Nevrol. Psikhiat., 7, 4–7 (1999).
V. V. Kalinin and D. A. Polyanskii, “Risk factors for the development of suicidal behavior in patients with epilepsy,” Zh. Nevrol. Psikhiat., 103, No. 3, 18–21 (2003).
S. N. Mosolov, Clinical Use of Contemporary Antidepressants [in Russian], MIA, St. Petersburg (1995).
D. A. Polyanskii, Clinical-Therapeutic Risk Factors for Suicidal Behavior in Patients with Epilepsy [in Russian], Author’s Abstract of Master’s Thesis in Medical Sciences, Moscow (2003).
J. Barry, A. Membke, and N. Huynh, Affective Disorders in Epilepsy. Psychiatric Issues in Epilepsy. A Practical Guide to Diagnosis and Treatment, A. Ettinger and A. Kanner (eds.), LWW, Philadelphia (2001), pp. 45–71.
P. Blanchet and G. P. Frommer, “Mood change preceding epileptic seizures,” J. Nerv. Ment. Dis., 174, 471–476 (1986).
D. Blum, M. Reed, and A. Metz, “Prevalence of major affective disorders and manic-hypomanic symptoms in persons with epilepsy: a community survey,” Neurology, Supplement 3, A175 (2002).
D. Blumer and L. L. Altschuler, “Affective disorders,” in: Epilepsy: A Comprehensive Textbook,” J. Engel and T. A. Pedley (eds.), Lipincott Raven, Philadelphia (1998), pp. 2083–2099.
D. Blumer, “Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders,” Harvard Rev. Psychiat., 8, 8–17 (2000).
D. Blumer, “Epilepsy and Suicide: A neuropsychiatric analysis,” in: The Neuropsychiatry of Epilepsy, M. Trimble and B. Schmitz (eds.), Cambridge (2002), 107–116.
L. Forsgren and L. Nystrom, “An incident case-referent study of epileptic seizures in adults,” Epilepsy Res., 6, 66–81 (1990).
F. Gilliam, “Optimizing health outcomes in active epilepsy,” Neurology, 58, Supplement 5, 9–20 (2002).
F. G. Gilliam, J. Santos, V. Vahle, et al., “Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?” Epilepsia, 46, Supplement 2, 28–33 (2004).
B. P. Herman, M. Seidenberg, A. Haltiner, et al., “Mood states in unilateral temporal lobe epilepsy,” Biol. Psychiat., 30, 1205–1218 (1991).
D. S. Hesdorffer, W. A. Hauser, and J. F. Annegers, “Major depression is a risk factor for seizures in older adults,” Ann. Neurol., 47, 246–249 (2000).
J. Hovorka, E. Herman, and I. Nemcova, “Treatment of interictal depression with citalopram in patients with epilepsy,” Epilepsy Behav., 1, 444–447 (2000).
A. Kanner and J. Nieto, “Depressive disorders in epilepsy,” Neurology, 53, Suppl. 2, 26–32 (1999).
A. M. Kanner, A. M. Kozak, and M. Frey, “The use of sertralin in patients with epilepsy: is it safe,” Epilepsy Behav., 1, No. 2, 100–105 (2000).
A. M. Kanner and A. Balabanov, “Depression and epilepsy: how closely related are they?” Neurology, 58, No. 8, Supplement 5, 27–39 (2002).
A. M. Kanner, J. Wuu, et al., “A past psychiatric history may be a risk factor for topiramat-related psychiatric and cognitive adverse events,” Epilepsy Behav., 4, 548–552 (2003).
A. M. Kanner, A. Soto, et al., “Prevalence and clinical characteristic of postictal psychiatric symptoms in partial epilepsy,” Neurology, 62, 708–713 (2004).
A. Kanner, Depression in Neurological Disorders, Cambridge Med. Commun. Ltd., Lundbeck Institute (2005).
M. F. Mendez, J. Cummings, D. Benson, et al., “Depression in epilepsy. Significance and phenomenology,” Arch. Neurol., 43, 766–770 (1986).
C. M. Michaud, C. J. Murray, and C. M. Bloom, “Burden of disease: Implications for future research,” J. Am. Med. Assoc., 285, 535–539 (2001).
M. Mula, M. R. Trimble, and J. W. Sander, “The role of hippocampal sclerosis in topiramate–related depression and cognitive deficits in people with epilepsy,” Epilepsia, 44, No. 12, 1573–1577 (2003).
M. Mula and J. W. Sander, “Suicidal ideation in epilepsy and levetiracetam therapy,” Epilepsy Behav., 11, 130–132 (2007).
M. Mula and J. W. Sander, “Negative effects of antiepileptic drugs on mood in patient with epilepsy,” Drug. Saf., 30, No. 7, 555–567 (2007).
S. Paradiso, B. P. Hermann, D. Blumer, et al., “Impact of depressed mood on neuropsychological status in temporal lobe epilepsy,” J. Neurol. Neurosurg. Psychiat., 70, 180–185 (2001).
K. Perrine, B. P. Hermann, K. J. Meador, et al., “The relationship of neuropsychological functioning to quality of life in epilepsy,” Arch. Neurol., 52, 997–1003 (1995).
A. Quiske, C. Helmstaedter, et al., “Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis,” Epilepsy Res., 39, No. 2, 121–125 (2000).
G. Savard, L. F. Andermann, et al., “Epilepsy, surgical treatment and postoperative psychiatric complications: A re-evaluation of the evidence,” in: Forced Normalization and Alternative Psychosis of Epilepsy. M. R. Trimble and B. Schmitz (eds.), Writson Biomedical Publishing Ltd., Petersfield (1998), pp. 179–192.
B. Schmitz and P. Wolf, “Psychosis with epilepsy: frequency and risk factors,” J. Epilepsy, 8, 295–305 (1995).
B. Schmitz, “Depression and mania in patients with epilepsy,” Epilepsia, 46, Supplement, 45 (2005).
D. Smith and J. Collins, “Behavioral effects of carbamazepine, phenobarbital, phenytoin and primidone,” Epilepsia, 28, 598 (1987).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 109, No. 11, Epilepsy, Iss. 2, pp. 52–57, November, 2009.
Rights and permissions
About this article
Cite this article
Bilalova, P.I., Lebedeva, A.V., Kovaleva, I.Y. et al. Some Characteristics of Emotional Disorders in Epilepsy. Neurosci Behav Physi 41, 68–73 (2011). https://doi.org/10.1007/s11055-010-9381-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-010-9381-6